Your browser doesn't support javascript.
loading
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology.
Metra, Marco; Tomasoni, Daniela; Adamo, Marianna; Bayes-Genis, Antoni; Filippatos, Gerasimos; Abdelhamid, Magdy; Adamopoulos, Stamatis; Anker, Stefan D; Antohi, Laura; Böhm, Michael; Braunschweig, Frieder; Gal, Tuvia Ben; Butler, Javed; Cleland, John G F; Cohen-Solal, Alain; Damman, Kevin; Gustafsson, Finn; Hill, Loreena; Jankowska, Ewa A; Lainscak, Mitja; Lund, Lars H; McDonagh, Theresa; Mebazaa, Alexandre; Moura, Brenda; Mullens, Wilfried; Piepoli, Massimo; Ponikowski, Piotr; Rakisheva, Amina; Ristic, Arsen; Savarese, Gianluigi; Seferovic, Petar; Sharma, Rajan; Tocchetti, Carlo Gabriele; Yilmaz, Mehmet Birhan; Vitale, Cristiana; Volterrani, Maurizio; von Haehling, Stephan; Chioncel, Ovidiu; Coats, Andrew J S; Rosano, Giuseppe.
Affiliation
  • Metra M; Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
  • Tomasoni D; Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
  • Adamo M; Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
  • Bayes-Genis A; Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, CIBERCV, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Filippatos G; Department of Cardiology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Abdelhamid M; Faculty of Medicine, Cairo University, Giza, Egypt.
  • Adamopoulos S; 2nd Department of Cardiovascular Medicine, Onassis Cardiac Surgery Center, Athens, Greece.
  • Anker SD; Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Centre for Cardiovascular Research (DZHK), partner site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Antohi L; Emergency Institute for Cardiovascular Diseases 'Prof. C.C. Iliescu', Bucharest, Romania.
  • Böhm M; University of Medicine Carol Davila, Bucharest, Romania.
  • Braunschweig F; Saarland University Hospital, Homburg/Saar, Germany.
  • Gal TB; Department of Medicine, Karolinska Institutet, and Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
  • Butler J; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Cleland JGF; Baylor Scott and White Research Institute, Dallas, TX, USA; Department of Medicine, University of Mississippi, Jackson, MS, USA.
  • Cohen-Solal A; British Heart Foundation Centre of Research Excellence, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
  • Damman K; Inserm 942 MASCOT, Université de Paris, AP-HP, Hopital Lariboisière, Paris, France.
  • Gustafsson F; University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands.
  • Hill L; Rigshospitalet-Copenhagen University Hospital, Heart Centre, Department of Cardiology, Copenhagen, Denmark.
  • Jankowska EA; Queen's University Belfast, Belfast, UK.
  • Lainscak M; Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
  • Lund LH; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia; Division of Cardiology, General Hospital Murska Sobota, Murska Sobota, Slovenia.
  • McDonagh T; Department of Medicine, Karolinska Institutet, and Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
  • Mebazaa A; Department of Cardiovascular Science, Faculty of Life Science and Medicine, King's College London, London, UK.
  • Moura B; Université Paris Cité, Inserm MASCOT, AP-HP Department of Anesthesia and Critical Care, Hôpital Lariboisière, Paris, France.
  • Mullens W; Faculty of Medicine, University of Porto, Porto, Portugal.
  • Piepoli M; Cardiology Department, Porto Armed Forces Hospital, Porto, Portugal.
  • Ponikowski P; Hospital Oost-Limburg, Genk, Belgium.
  • Rakisheva A; Clinical Cardiology, IRCCS Policlinico San Donato, Milan, Italy.
  • Ristic A; Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.
  • Savarese G; Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
  • Seferovic P; Scientific Research Institute of Cardiology and Internal Medicine, Almaty, Kazakhstan.
  • Sharma R; School of Medicine, University of Belgrade, Belgrade, Serbia.
  • Tocchetti CG; Department of Medicine, Karolinska Institutet, and Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
  • Yilmaz MB; School of Medicine, University of Belgrade, Belgrade, Serbia.
  • Vitale C; St. George's Hospitals NHS Trust University of London, London, UK.
  • Volterrani M; Department of Translational Medical Sciences (DISMET), Center for Basic and Clinical Immunology Research (CISI), Interdepartmental Center of Clinical and Translational Sciences (CIRCET), Interdepartmental Hypertension Research Center (CIRIAPA), Federico II University, Naples, Italy.
  • von Haehling S; Department of Cardiology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
  • Chioncel O; Department of Medical Sciences, Centre for Clinical and Basic Research, IRCCS San Raffaele Pisana, Rome.
  • Coats AJS; Department of Medical Sciences, Centre for Clinical and Basic Research, IRCCS San Raffaele Pisana, Rome.
  • Rosano G; Department of Cardiology and Pneumology, University Medical Center Goettingen, Georg-August University, Goettingen, Germany.
Eur J Heart Fail ; 25(6): 776-791, 2023 06.
Article in En | MEDLINE | ID: mdl-37208936
ABSTRACT
Episodes of worsening symptoms and signs characterize the clinical course of patients with chronic heart failure (HF). These events are associated with poorer quality of life, increased risks of hospitalization and death and are a major burden on healthcare resources. They usually require diuretic therapy, either administered intravenously or by escalation of oral doses or with combinations of different diuretic classes. Additional treatments may also have a major role, including initiation of guideline-recommended medical therapy (GRMT). Hospital admission is often necessary but treatment in the emergency service or in outpatient clinics or by primary care physicians has become increasingly used. Prevention of first and recurring episodes of worsening HF is an essential component of HF treatment and this may be achieved through early and rapid administration of GRMT. The aim of the present clinical consensus statement by the Heart Failure Association of the European Society of Cardiology is to provide an update on the definition, clinical characteristics, management and prevention of worsening HF in clinical practice.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiology / Heart Failure Type of study: Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Eur J Heart Fail Journal subject: CARDIOLOGIA Year: 2023 Document type: Article Affiliation country: Italia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiology / Heart Failure Type of study: Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Eur J Heart Fail Journal subject: CARDIOLOGIA Year: 2023 Document type: Article Affiliation country: Italia